Bayer ($BAYRY) $38M Investor Settlement
Bayer ($BAYRY) has agreed to settle $38 million with investors to resolve claims that it misled them about its due diligence in acquiring Monsanto and the legal risks tied to Roundup-related litigation.
Outline:
Bayer announced plans to acquire Monsanto as part of a major expansion in the agricultural chemicals market. Investors later alleged the company failed to disclose the full scope of litigation risks tied to Roundup. After several jury verdicts in Roundup cancer trials raised concerns about those risks, the stock declined. Investors filed suit and Bayer later agreed to a $38 million settlement.
Timeline:
May 23, 2016: Bayer announced plans to acquire Monsanto for $122 per share.
June 2018: Bayer completed the $63 billion acquisition of Monsanto.
August 10, 2018: A California jury awarded $289 million in the first Roundup cancer trial.
March 19, 2019: After another adverse verdict, $BAYRY declined about 11%.
July 15, 2020: Investors filed a securities class action lawsuit against Bayer.
April 23, 2025: Bayer agreed to a $38 million settlement to resolve the claims.
Background:
Bayer is a multinational pharmaceutical and agricultural company that acquired Monsanto in 2018 in a transaction valued at approximately $63 billion. The acquisition was intended to expand Bayer’s position in the global agricultural chemicals and seed markets.
Before completing the transaction, Bayer stated that it had conducted due diligence regarding potential legal risks associated with Monsanto’s products, including Roundup, a widely used herbicide containing glyphosate.
Shortly after the acquisition closed, several U.S. jury verdicts found that Roundup exposure contributed to cases of non-Hodgkin’s lymphoma. These rulings raised concerns about the scale of potential litigation exposure tied to the product.
Investors later alleged that Bayer did not adequately disclose the extent of the litigation risks associated with the acquisition. Following the trial verdicts and related developments, Bayer’s share price declined and shareholders filed a securities class action lawsuit.
What Can Investors Expect Now?
Bayer agreed to a $38 million settlement with $BAYRY investors to resolve claims that it misled them about legal risks associated with its acquisition of Monsanto.
If you were damaged due to this situation, you can file for a payout and get your share of the settlement. You can check if you are eligible and other details in the FAQ section.
Frequently Asked Questions
All persons or entities that purchased or otherwise acquired Bayer American Depositary Receipts (ADRs) between May 23, 2016 and July 6, 2020, inclusive.
No, if you have purchased securities within the class period, you are eligible to participate.
You can participate in the settlement and retain (or sell) your securities.
The entire process usually takes 4 to 9 months after the claim deadline. But the exact timing depends on the court and settlement administration.
The final payout amount depends on your specific trades and the number of investors participating in the settlement.
If 100% of investors file their claims - the average payout will be $0.23 per share. Although typically only 25% of investors file claims, in this case, the average recovery will be $0.92 per share.
If you're eligible, you can file your claim directly from this case page by clicking the "Collect Payout" button.
More than 100 companies are currently paying out settlements. Connect your brokerage account to automatically check which ones you may have missed — or file manually for this case.
11th.com is an investor recovery company that helps investors track and collect securities class action settlements. We will:
1. Prepare documents for your payout.
2. Audit the claim and make sure you get the maximum possible payout.
3. File a claim with the settlement administration.
4. Correspond with the settlement administration to resolve emerging issues.
5. Deliver payout directly to your brokerage account.
There is no upfront cost, but we will deduct 20% of the recovered amount as a commission for our services.